Bruno Cortes Aragão, MD

Articles by Bruno Cortes Aragão, MD

Gemcitabine and Paclitaxel as Salvage Therapy in Metastatic Breast Cancer

ByAndre Marcio Murad, MD, PhD,Rodrigo Cunha Guimarães, MD,Bruno Cortes Aragão, MD,Antonio Orlando Scalabrini-neto, MD,Victor Hugo Rodrigues, MD,Renato Garcia

February 1st 2001

In a phase II trial, 29 patients with anthracycline-pretreated or anthracycline-resistant metastatic breast cancer in whom anthracycline-containing first- or second-line chemotherapy failed received combination paclitaxel

Latest Updated Articles

Gemcitabine and Paclitaxel as Salvage Therapy in Metastatic Breast Cancer
February 1st 2001

Bruno Cortes Aragão, MD

Articles by Bruno Cortes Aragão, MD

Gemcitabine and Paclitaxel as Salvage Therapy in Metastatic Breast Cancer

Latest Updated Articles

Trending on CancerNetwork

FDA Approves Afami-cel in Metastatic Synovial Sarcoma

EC Approves Encorafenib/Cetuximab/FOLFOX in 1L BRAF V600E–Mutant mCRC

The Moonlight Shift: Dr Joshua Richter on Myeloma, Myths, and the C-Word

Binimetinib Tablets Receive Tentative FDA Approval in Melanoma/NSCLC

How Are Key Lymphoma Data From ASCO and EHA 2026 Shaping Treatment?